JW Pharmaceutical Corporation
Japan Drug Master Files (JDMF)

JW Pharmaceutical Corporation

Japan DMF Database

Japan Drug Master Files (JDMF) registered with Japan's Pharmaceuticals and Medical Devices Agency (PMDA).

APIs
  • Total Records 6
  • Latest Registration 2023-11-29
  • Data Source PMDA
  • Last Updated 2023-11-29
Company Overview

Company

JW Pharmaceutical Corporation

Country

South Korea

Website

Visit Website

Email

info@cwholdings.co.kr

Social Profiles

Company Snapshot

JW Pharmaceutical Corporation

2477, Nambusunhwan-ro, Seocho-gu, Seoul, 137-864

South Korea

www.jw-pharma.co.kr/ info@cwholdings.co.kr View on Map
JDMF Records Timeline (6 records)
2016
27 Jul
APIs 228MF10137

Product

Anagliptin

Company

JW Pharmaceutical Corporation

MF Registration No.

228MF10137

Domestic Manager

Initial Registration

2016-07-27

Latest Registration

2023-11-29

Registered Address

38, Gwacheon-daero 7-gil, Gwacheon-si, Gyeonggi-do, Republic of Korea

Country

Identifiers

MF Registration No.: 228MF10137

2006
27 Apr
APIs 218MF10470

Product

Itraconazole

Company

JW Pharmaceutical Corporation

MF Registration No.

218MF10470

Domestic Manager

Initial Registration

2006-04-27

Latest Registration

2023-04-12

Registered Address

38, Gwacheon-daero 7-gil, Gwacheon-si, Gyeonggi-do, Republic of Korea

Country

Identifiers

MF Registration No.: 218MF10470

2015
31 Aug
APIs 227MF10215

Product

Montelukast sodium

Company

JW Pharmaceutical Corporation

MF Registration No.

227MF10215

Domestic Manager

Initial Registration

2015-08-31

Latest Registration

2018-07-20

Registered Address

2477, Nambusunhwan-ro Seocho-gu, Seoul, Republic of Korea

Country

Identifiers

MF Registration No.: 227MF10215

2016
31 Oct
APIs 228MF10203

Product

AZOSEMIDE

Company

JW Pharmaceutical Corporation

MF Registration No.

228MF10203

Domestic Manager

Initial Registration

2016-10-31

Latest Registration

2016-10-31

Registered Address

2477, Nambusunhwan-ro, Seocho-gu, Seoul Republic of Korea

Country

Identifiers

MF Registration No.: 228MF10203

2015
23 Jan
APIs 227MF10030

Product

Olanzapine

Company

JW Pharmaceutical Corporation

MF Registration No.

227MF10030

Domestic Manager

Initial Registration

2015-01-23

Latest Registration

2015-11-11

Registered Address

2477, Nambusunhwan-ro Seocho-gu, Seoul, Republic of Korea

Country

Identifiers

MF Registration No.: 227MF10030

2008
31 Jul
APIs 220MF10186

Product

Cefmetazole sodium

Company

JW Pharmaceutical Corporation

MF Registration No.

220MF10186

Domestic Manager

Initial Registration

2008-07-31

Latest Registration

2008-07-31

Registered Address

2477, Nambusunhwan-ro Seocho-gu, Seoul, Republic of Korea

Country

Identifiers

MF Registration No.: 220MF10186

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    6 View
  • Eudra GMP
    0 View
Category Breakdown
6 total
  • APIs
Official Source

All data is sourced from publicly available Japanese pharmaceutical regulatory sources and PMDA related publications.

Visit PMDA
Record Details Preview

Click "View Details" on any record above to expand full details inline.

Country

Identifiers

MF Registration No.: 228MF10137

100% Official Data

Compiled from official PMDA & Japanese regulatory sources

Regular Updates

Data updated regularly from official sources

Trusted by Professionals

100K+ pharma professionals worldwide

Secure & Reliable

Enterprise-grade security and data protection

Japan DMF (JDMF) data is compiled from publicly available Japanese pharmaceutical regulatory sources and PMDA related publications.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit